Five years after the World Health Organization declared a global pandemic, there has been progress — and backsliding in the ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...

The pandemic accelerated economic disparity, revealing a disturbing acceptance of mass death. Did we learn nothing?

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...

Five young volunteers here have been deliberately exposed to the Covid-19 virus in the country’s first human challenge study, ...

Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...